Technical Analysis for FRPRF - 4D Pharma Plc.

Grade Last Price % Change Price Change
C 1.71 -2.29% -0.0400
FRPRF closed down 2.29 percent on Wednesday, January 20, 2021, on 6 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Flat
Historical FRPRF trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Gapped Down Weakness 0.00%
Narrow Range Bar Range Contraction -2.29%
Stochastic Reached Overbought Strength -2.29%
Wide Bands Range Expansion -2.29%
Overbought Stochastic Strength -2.29%
Gapped Down Weakness -2.29%
Narrow Range Bar Range Contraction -5.00%
Older End-of-Day Signals for FRPRF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

4D Pharma Plc. Description

4D pharma plc, together with its subsidiaries, engages in the research, development, and production of live biotherapeutic products. The company's development programs include Blautix for irritable bowel syndrome and Thetanix for paediatric crohn's disease. It also develops immuno-oncology products comprising MRx0518, MRx0573, and MRx1299 for solid tumors, and MRx0518 for pancreatic cancer; respiratory products, such as MRx-4DP0004 for asthma and COVID-19; central nervous system products, including MRx0005 and MRx0029 for neurodegeneration; and platform products comprising vaccines and autoimmune. 4D pharma plc has a collaboration agreement with Merck & Co., Inc. to conduct a clinical trial evaluating the combination of Keytruda and MRx0518 in patients with solid tumours. The company was formerly known as Schosween 18 Limited. 4D pharma plc was founded in 2014 and is headquartered in Leeds, the United Kingdom.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medical Specialties Clinical Medicine Immunology Vaccines Solid Tumors Asthma Therapeutic Product Cancer Immunotherapy Therapeutic Products New Jersey E Combination Pancreatic Pancreatic Cancer Merck Bayer Crohn's Disease Oncology Products Irritable Bowel Syndrome Merck & Co. Neurodegeneration Tumour Immuno Oncology Products Kenilworth Nervous System Products Respiratory Products Schering Plough Tumours

Is FRPRF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.2
52 Week Low 1.09
Average Volume 9,783
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 1.5928
10-Day Moving Average 1.7090
Average True Range 0.2162
ADX 13.07
+DI 51.7564
-DI 40.2597
Chandelier Exit (Long, 3 ATRs ) 1.2514
Chandelier Exit (Short, 3 ATRs ) 1.8586
Upper Bollinger Band 2.0811
Lower Bollinger Band 1.1045
Percent B (%b) 0.62
BandWidth 61.3134
MACD Line 0.0301
MACD Signal Line 0.0079
MACD Histogram 0.0221
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.7100
Resistance 3 (R3) 1.7100 1.7100 1.7100
Resistance 2 (R2) 1.7100 1.7100 1.7100 1.7100
Resistance 1 (R1) 1.7100 1.7100 1.7100 1.7100 1.7100
Pivot Point 1.7100 1.7100 1.7100 1.7100 1.7100
Support 1 (S1) 1.7100 1.7100 1.7100 1.7100 1.7100
Support 2 (S2) 1.7100 1.7100 1.7100 1.7100
Support 3 (S3) 1.7100 1.7100 1.7100
Support 4 (S4) 1.7100